All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

UCB cuts price, extends €1bn revolver

Belgian pharmaceutical firm UCB has become the latest western European firm to reduce the cost of its bank debt, after closing an amend-and-extend agreement on a €1bn revolving credit facility.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree